Peripheral arterial disease natural history, complications and prognosis

Jump to navigation Jump to search

Peripheral arterial disease Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Peripheral arterial disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Management

Case Studies

Case #1

AHA/ACC Guidelines on Management of Lower Extremity PAD

Guidelines for Clinical Assessment of Lower Extremity PAD

Guidelines for Diagnostic Testing for suspected PAD

Guidelines for Screening for Atherosclerotic Disease in Other Vascular Beds in patients with Lower Extremity PAD

Guidelines for Medical Therapy for Lower Extremity PAD

Guidelines for Structured Exercise Therapy for Lower Extremity PAD

Guidelines for Minimizing Tissue Loss in Lower Extremity PAD

Guidelines for Revascularization of Claudication in Lower Extremity PAD

Guidelines for Management of CLI in Lower Extremity PAD

Guidelines for Management of Acute Limb Ischemial in Lower Extremity PAD

Guidelines for Longitudinal Follow-up for Lower Extremity PAD

Peripheral arterial disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peripheral arterial disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peripheral arterial disease natural history, complications and prognosis

CDC on Peripheral arterial disease natural history, complications and prognosis

Peripheral arterial disease natural history, complications and prognosis in the news

Blogs on Peripheral arterial disease natural history, complications and prognosis

Directions to Hospitals Treating Peripheral arterial disease

Risk calculators and risk factors for Peripheral arterial disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Aarti Narayan, M.B.B.S [3]; Rim Halaby

Overview

Most patients with peripheral arterial disease (PAD) have a benign course, with the majority of patients being asymptomatic. However, clinical manifestations may progress rapidly in smokers, patients with diabetes and patients with chronic renal failure. Peripheral arterial disease is associated with complications that include ischemic leg pain at rest, ulceration and gangrene. In addition, the mortality rate among patients with peripheral arterial disease is higher than that of the general population. Mortality is mainly due to concomitant coronary artery disease and cerebrovascular disease rather than to the peripheral arterial disease itself.

Natural History

  • Patients with peripheral arterial disease can be asymptomatic, have non critical symptoms or have critical symptoms that include ischemic leg pain, leg ulcers and gangrene. In fact, 20% to 50% of patients with peripheral arterial disease are asymptomatic.[1]
  • The need of revascularization and amputation is relatively low. Lifestyle modifications and medical management is sufficient to treat asymptomatic to mild PAD. However, severe ischemia requires revascularization surgeries as definitive treatment.
  • The progression of non critical claudication symptoms is as follows:
    • Symptoms remain stable in 70-80% of patients within five years.
    • Symptoms worsen in 10-20% of patients within five years and can include rest pain, ulcers and gangrene.
    • Symptoms progress to critical limb ischemia in 1-2% within five years.[2]

Below is an image summarizing the natural history of PAD. To note is that mortality in PAD is related to associated cardiovascular disease rather than PAD per se:

Natural history of PAD
Natural history of PAD

Complications

  • Patients with PAD are at a higher risk for major cardiovascular events, especially myocardial infarction (MI), stroke and death which are related to the atherosclerotic pathophysiological basis of PAD and not directly related to PAD itself.
  • Patients limb-related complications directly linked to the PAD may include:
    • Blood clots or emboli that block off small arteries
    • Lower extremity ulcers
    • Gangrene
    • Need for amputation.
  • Amputation:
  • The rate of amputation is relatively low in patients with PAD and it is estimated to be almost 1% per year.
  • Patients who do not quit smoking have two fold higher risk of amputation than patients who quit smoking.
  • Patients who have diabetes have 25% risk of amputation within 10 years.
  • Patients who present with acute critical limb ischemia have 10 to 30% risk of amputation within 30 days.[3]

Prognosis

Mortality

  • Patients with peripheral arterial disease have a 15 to 30 % five year mortality rate, which is two to six times higher than that of the general population.
  • The mortality associated with the peripheral vascular disease is rarely directly related to the disease itself but it is rather related to the co-existing coronary and cerebrovascular diseases.[3]
  • Patients with PAD have a twofold to fourfold increase in the risk of all-cause mortality and a threefold to sixfold increase in the risk of cardiovascular death compared to patients without PAD.
  • All patients with PAD should be targeted with the same secondary prevention goals as patients with coronary artery disease.

Shown below is an image depicting the overlap between peripheral artery disease, cardiovascular disease and cerebrovascular disease:

Overlap between PAD, CAD and CVD
Overlap between PAD, CAD and CVD

The Factors that Influence the Mortality in PAD

  • Severity of symptoms:
  • ABI:
  • Normal ABI in the presence of symptoms: no change in the mortality rate
  • ABI < 0.85: 10% five year mortality rate
  • ABI < 0.4: 50% one year mortality rate
  • Two fold increase in mortality
  • Increase in all causes of mortality
  • Location of the arterial occlusive disease:
  • Aorticoliliac: 73% five year survival
  • Femoral: 80% five year survival[2]

Five Year Primary Patency Rates Following Bypass Grafting

Shown below is a table depicting the five year primary patency rates in affected vessels following angioplasty with or without stenting versus that following bypass grafting:

Location Angioplasty ± Stenting Bypass grafting
Distal aorta/proximal common iliac artery 51 - 88% 80 - 90%
Distal common iliac artery 56 - 65% Vein: 60 - 75%, Synthetic: 55 - 62%
Proximal external iliac artery 40 - 56% Vein: 60 - 70%, Synthetic: 55 - 62%
Distal external iliac artery 10 - 40% Vein: 50 - 60%, Synthetic: 10 - 15%

References

  1. McDermott MM, Guralnik JM, Ferrucci L; et al. (2008). "Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication". Circulation. 117 (19): 2484–91. doi:10.1161/CIRCULATIONAHA.107.736108. PMID 18458172. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Spittel P. Chapter 44. Peripheral vascular Disease. In Murphy J, Lloyd M,Mayo Clinic Cardiology Concise Textbook. Fourth edition.Mayo clinic scientific press.2013
  3. 3.0 3.1 Wennberg PW, Rooke TW. Chapter 109. Diagnosis and Management of Diseases of the Peripheral Arteries and Veins. In: Fuster V, Walsh RA, Harrington RA, eds. Hurst's The Heart. 13th ed. New York: McGraw-Hill; 2011.
  4. Dhaliwal G, Mukherjee D (2007). "Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment". The International Journal of Angiology : Official Publication of the International College of Angiology, Inc. 16 (2): 36–44. PMC 2733014. PMID 22477268.
  5. Mendelson G, Aronow WS, Ahn C (1998). "Prevalence of coronary artery disease, atherothrombotic brain infarction, and peripheral arterial disease: associated risk factors in older Hispanics in an academic hospital-based geriatrics practice". Journal of the American Geriatrics Society. 46 (4): 481–3. PMID 9560072. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources